- Home
- CDTX vs FCO Comparison
CDTX vs FCO Comparison
Compare CDTX & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- FCO
- Stock Information
- Founded
- CDTX 2012
- FCO 1991
- Country
- CDTX United States
- FCO United Kingdom
- Employees
- CDTX N/A
- FCO N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- FCO Investment Managers
- Sector
- CDTX Health Care
- FCO Finance
- Exchange
- CDTX Nasdaq
- FCO Nasdaq
- Market Cap
- CDTX 79.3M
- FCO 81.4M
- IPO Year
- CDTX 2015
- FCO N/A
- Fundamental
- Price
- CDTX $14.37
- FCO $5.97
- Analyst Decision
- CDTX Strong Buy
- FCO
- Analyst Count
- CDTX 5
- FCO 0
- Target Price
- CDTX $30.50
- FCO N/A
- AVG Volume (30 Days)
- CDTX 21.1K
- FCO 100.1K
- Earning Date
- CDTX 11-07-2024
- FCO 01-01-0001
- Dividend Yield
- CDTX N/A
- FCO 14.96%
- EPS Growth
- CDTX N/A
- FCO N/A
- EPS
- CDTX N/A
- FCO 0.43
- Revenue
- CDTX $44,653,000.00
- FCO N/A
- Revenue This Year
- CDTX N/A
- FCO N/A
- Revenue Next Year
- CDTX N/A
- FCO N/A
- P/E Ratio
- CDTX N/A
- FCO $12.30
- Revenue Growth
- CDTX 19.60
- FCO N/A
- 52 Week Low
- CDTX $10.00
- FCO $4.73
- 52 Week High
- CDTX $24.40
- FCO $6.63
- Technical
- Relative Strength Index (RSI)
- CDTX 72.85
- FCO 48.57
- Support Level
- CDTX $12.89
- FCO $5.96
- Resistance Level
- CDTX $13.78
- FCO $6.16
- Average True Range (ATR)
- CDTX 0.70
- FCO 0.10
- MACD
- CDTX 0.13
- FCO -0.00
- Stochastic Oscillator
- CDTX 75.31
- FCO 43.18
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets, and Sub-Investment Grade Developing Markets.